FDA has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. This conclusion is based on our in-depth review of results from a safety clinical trial that found an increased risk of heart-related death and death from all causes with Uloric.
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of a probable human carcinogen.
NYC hospitals continues their poor performance on Leapfrog's hospital safety grades list, with most earning Cs or Ds. Healthcare providers in all five boroughs once again performed poorly in Leapfrog's* Fall 2018 ratings for hospital safety. More than 50% of 44 New York City facilities graded earned a C grade and only three facilities managed a B [...]